By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc. (UPC)

NASDAQ Currency in USD
$252.00
-$0.95
-0.37%
Last Update: 18 Jul 2026, 15:59
$876.46k
Market Cap
-0.11
P/E Ratio (TTM)
Forward Dividend Yield
$167.11-$339.12
52 Week Range

UPC Stock Price Chart

Explore Universe Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze UPC price movements and trends.

UPC Company Profile

Discover essential business fundamentals and corporate details for Universe Pharmaceuticals Inc. (UPC) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

23 Mar 2021

Employees

225.00

CEO

Gang Lai

Description

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

UPC Financial Timeline

Browse a chronological timeline of Universe Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 22 Apr 2026

Stock split effective on 24 Mar 2025

Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 18 Nov 2024

Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Apr 2024

Earnings released on 9 Feb 2024

Stock split effective on 28 Jul 2023

Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.

UPC Stock Performance

Access detailed UPC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run